Business ❯Pharmaceuticals

Drug Companies

Prevacus Eli Lilly and Novo Nordisk Johnson & Johnson Bristol Myers Squibb Novartis Biogen

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Novartis Acquires MorphoSys for $2.9 Billion, Expanding Cancer Drug Portfolio

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion